한빛사논문 | BRIC

박연희 님의 논문 목록

성균관대학교 의과대학, 삼성의료원

CV File 879 kb

Palbociclib plus endocrine therapy versus capecitabine in premenopausal women with hormone receptor-positive, HER2-negative metastatic breast cancer (Young-PEARL): overall survival analysis of a randomised, open-label, phase 2 study
- Lancet Oncol., Feb 17 2025, S1470-2045(25)00006-3 | https://doi.org/10.1016/S1470-2045(25)00006-3
- 2025-02
- 의약학
- 한빛사논문
Longitudinal multi-omics study of palbociclib resistance in HR-positive/HER2-negative metastatic breast cancer
- Genome Med., 2023 Jul 20;15(1):55 | https://doi.org/10.1186/s13073-023-01201-7
- 2023-07
- 의약학
- 한빛사논문
Response Rate and Safety of a Neoadjuvant Pertuzumab, Atezolizumab, Docetaxel, and Trastuzumab Regimen for Patients With ERBB2-Positive Stage II/III Breast Cancer The Neo-PATH Phase 2 Nonrandomized Clinical Trial
- JAMA Oncol., Published Online: July 7, 2022;8(9):1271-1277. | doi:10.1001/jamaoncol.2022.2310
- 2022-07
- 의약학
- 한빛사논문
Chemotherapy induces dynamic immune responses in breast cancers that impact treatment outcome
- Nat. Commun., Published: 02 December 2020, 11, 6175 | https://doi.org/10.1038/s41467-020-19933-0
- 2020-12
- 의약학
- 한빛사논문
- 박연희(성균관대학교 의과대학, 삼성서울병원)
A Phase Ib study of alpelisib or buparlisib combined with tamoxifen plus goserelin in premenopausal women with HR-positive HER2-negative advanced breast cancer
- Clin. Cancer Res., Published Online First July 27, 2020 | doi: 10.1158/1078-0432.CCR-20-1008
- 2020-07
- 의약학
- 한빛사논문
Palbociclib plus exemestane with gonadotropin-releasing hormone agonist versus capecitabine in premenopausal women with hormone receptor-positive, HER2-negative metastatic breast cancer (KCSG-BR15-10): a multicentre, open-label, randomised, phase 2 trial
- Lancet Oncol., Available online 24 October 2019 | https://doi.org/10.1016/S1470-2045(19)30565-0
- 2019-10
- 의약학
- 한빛사논문
Multi-omics profiling of younger Asian breast cancers reveals distinctive molecular signatures.
- Nat. Commun., Published online: 30 April 2018, 9, Article number: 1725 | doi:10.1038/s41467-018-04129-4
- 2018-04
- 의약학
- 한빛사논문
Extranodal Natural Killer T-Cell Lymphoma, Nasal-Type: A Prognostic Model From a Retrospective Multicenter Study
- J. Clin. Oncol., February 1, 2006 vol. 24 no. 4 612-618, doi: 10.1200/JCO.2005.04.1384
- 2006-02
- 의약학
- 상위피인용논문
Phase III, Multicenter, Randomized Trial of Maintenance Chemotherapy Versus Observation in Patients With Metastatic Breast Cancer After Achieving Disease Control With Six Cycles of Gemcitabine Plus Paclitaxel As First-Line Chemotherapy: KCSG-BR07-02
- J. Clin. Oncol., Published online before print April 8, 2013, doi: 10.1200/JCO.2012.45.2490
- 2013-04
- 의약학
- 한빛사논문

저자논문

저자논문

저자논문

저자논문

CV 열람하기

연락처 보기